SGHT · Sight Sciences Inc. Common Stock
View on chartInsiders & Stakes
| Paul Badawi President and CEO | ▼ Sell | Open Market | 6,092,819 Shares held | 10/1/2026 | View profile |
| D1 Capital Partners L.P. 10% Owner | ▼ Sell | Open Market | 3,000,000 Shares held | 12/27/2023 | View profile |
| David Badawi Chief Technology Officer | ▼ Sell | Open Market | 1,975,075 Shares held | 10/1/2026 | View profile |
| Staffan Encrantz Director | ▲ Buy | Open Market | 1,434,283 Shares held | 6/10/2026 | View profile |
| Link Matthew Chief Commercial Officer | ▼ Sell | Open Market | 832,293 Shares held | 7/2/2025 | View profile |
| Alison Bauerlein Chief Operating Officer | ▼ Sell | Open Market | 639,449 Shares held | 10/2/2026 | View profile |
| Selnick Jesse Chief Financial Officer | ▼ Sell | Tax Withholding | 403,359 Shares held | 1/4/2023 | View profile |
| Jeremy B. Hayden Chief Legal Officer | ▼ Sell | Open Market | 357,037 Shares held | 7/6/2026 | View profile |
| Brenton Taylor EVP, Operations & R&D | ▼ Sell | Open Market | 261,990 Shares held | 10/2/2026 | View profile |
| Park Sam Boong Chief Operating Officer | ▼ Sell | Open Market | 254,826 Shares held | 10/1/2024 | View profile |
| James Rodberg Chief Financial Officer | ▼ Sell | Open Market | 216,829 Shares held | 10/2/2026 | View profile |
| Donald Zurbay Director | ▲ Buy | Grant | 193,613 Shares held | 6/4/2026 | View profile |
| Rashid Kashif Chief Legal Officer | ▲ Buy | Grant | 181,818 Shares held | 8/10/2026 | View profile |
| Erica J. Rogers Director | ▲ Buy | Grant | 175,352 Shares held | 6/5/2025 | View profile |
| Raheja Manohar K. EVP, Research & Development | ▲ Buy | Grant | 167,767 Shares held | 5/16/2025 | View profile |
| Gerhard F. Burbach Director | ▲ Buy | Grant | 123,207 Shares held | 6/4/2026 | View profile |
| Tamara Fountain Director | ▲ Buy | Grant | 109,650 Shares held | 6/4/2026 | View profile |
| Larsen-Becker Brenda Jane Director | ▲ Buy | Grant | 79,040 Shares held | 6/5/2025 | View profile |
| Catherine Mazzacco Director | ▲ Buy | Grant | 69,276 Shares held | 6/4/2026 | View profile |
| Schroeder Valeska Director | ▲ Buy | Grant | 11,940 Shares held | 6/8/2023 | View profile |
| Hicks Mack H. Director | ▼ Sell | Other | 0 Shares held | 7/6/2022 | View profile |
Transaction History
| Brenton Taylor | ▼ Sell | Open Market | 2,988 | $26K | 10/2/2026 |
| Alison Bauerlein | ▼ Sell | Open Market | 25,260 | $224K | 10/2/2026 |
| James Rodberg | ▼ Sell | Open Market | 7,208 | $64K | 10/2/2026 |
| David Badawi | ▼ Sell | Open Market | 7,797 | $71K | 10/1/2026 |
| Paul Badawi | ▼ Sell | Open Market | 29,653 | $268K | 10/1/2026 |
| Rashid Kashif | ▲ Buy | Grant | 181,818 | $0 | 8/10/2026 |
| David Badawi | ▼ Sell | Open Market | 7,418 | $41K | 7/6/2026 |
| Jeremy B. Hayden | ▼ Sell | Open Market | 12,733 | $70K | 7/6/2026 |
| James Rodberg | ▼ Sell | Open Market | 6,902 | $37K | 7/2/2026 |
| Alison Bauerlein | ▼ Sell | Open Market | 24,184 | $130K | 7/2/2026 |
| Brenton Taylor | ▼ Sell | Open Market | 2,829 | $15K | 7/1/2026 |
| Paul Badawi | ▼ Sell | Open Market | 28,684 | $155K | 7/1/2026 |
| Staffan Encrantz | ▲ Buy | Open Market | 14,100 | $69K | 6/10/2026 |
| Tamara Fountain | ▲ Buy | Grant | 28,261 | $0 | 6/4/2026 |
| Staffan Encrantz | ▲ Buy | Grant | 28,261 | $0 | 6/4/2026 |
| Gerhard F. Burbach | ▲ Buy | Grant | 28,261 | $0 | 6/4/2026 |
| Donald Zurbay | ▲ Buy | Grant | 28,261 | $0 | 6/4/2026 |
| Catherine Mazzacco | ▲ Buy | Grant | 28,261 | $0 | 6/4/2026 |
| Alison Bauerlein | ▼ Sell | Open Market | 12,728 | $65K | 5/18/2026 |
| James Rodberg | ▼ Sell | Open Market | 7,231 | $26K | 4/6/2026 |
| Jeremy B. Hayden | ▼ Sell | Open Market | 13,761 | $49K | 4/6/2026 |
| David Badawi | ▼ Sell | Open Market | 8,168 | $28K | 4/2/2026 |
| Alison Bauerlein | ▼ Sell | Open Market | 25,874 | $90K | 4/2/2026 |
| Brenton Taylor | ▼ Sell | Open Market | 2,869 | $11K | 4/1/2026 |
| Paul Badawi | ▼ Sell | Open Market | 29,244 | $108K | 4/1/2026 |
| David Badawi | ▲ Buy | Option Exercise | 21,270 | $5K | 2/19/2026 |
| Brenton Taylor | ▲ Buy | Grant | 100,464 | $0 | 2/3/2026 |
| David Badawi | ▲ Buy | Grant | 64,915 | $0 | 2/3/2026 |
| Jeremy B. Hayden | ▲ Buy | Grant | 115,920 | $0 | 2/3/2026 |
| Paul Badawi | ▲ Buy | Grant | 154,560 | $0 | 2/3/2026 |
| James Rodberg | ▲ Buy | Grant | 86,940 | $0 | 2/3/2026 |
| Alison Bauerlein | ▲ Buy | Grant | 127,512 | $0 | 2/3/2026 |
| David Badawi | ▼ Sell | Open Market | 4,836 | $32K | 1/16/2026 |
| James Rodberg | ▼ Sell | Open Market | 2,616 | $17K | 1/16/2026 |
| Jeremy B. Hayden | ▼ Sell | Open Market | 6,308 | $42K | 1/16/2026 |
| Paul Badawi | ▼ Sell | Open Market | 22,362 | $148K | 1/16/2026 |
| Paul Badawi | ▼ Sell | Open Market | 11,870 | $89K | 1/6/2026 |
| Jeremy B. Hayden | ▼ Sell | Open Market | 1,785 | $13K | 1/6/2026 |
| James Rodberg | ▼ Sell | Open Market | 594 | $4K | 1/6/2026 |
| Alison Bauerlein | ▼ Sell | Open Market | 9,647 | $72K | 1/6/2026 |
| Brenton Taylor | ▼ Sell | Open Market | 619 | $5K | 1/6/2026 |
| David Badawi | ▼ Sell | Open Market | 3,695 | $28K | 1/6/2026 |
| Jeremy B. Hayden | ▼ Sell | Open Market | 9,385 | $73K | 1/5/2026 |
| James Rodberg | ▼ Sell | Open Market | 4,405 | $34K | 1/5/2026 |
| Alison Bauerlein | ▼ Sell | Open Market | 10,896 | $85K | 1/5/2026 |
| David Badawi | ▼ Sell | Open Market | 3,051 | $24K | 1/5/2026 |
| Paul Badawi | ▼ Sell | Open Market | 25,356 | $188K | 1/2/2026 |
| David Badawi | ▼ Sell | Open Market | 2,914 | $22K | 1/2/2026 |
| David Badawi | ▲ Buy | Option Exercise | 21,270 | $5K | 12/26/2025 |
| Staffan Encrantz | ▲ Buy | Open Market | 13,958 | $116K | 12/16/2025 |
| James Rodberg | ▼ Sell | Open Market | 2,518 | $21K | 12/2/2025 |
| Jeremy B. Hayden | ▲ Buy | Option Exercise | 37,560 | $74K | 11/25/2025 |
| Jeremy B. Hayden | ▲ Buy | Option Exercise | 7,290 | $14K | 11/25/2025 |
| Jeremy B. Hayden | ▼ Sell | Open Market | 44,850 | $362K | 11/25/2025 |
| Brenton Taylor | ▼ Sell | Open Market | 14,418 | $102K | 11/17/2025 |
| Jeremy B. Hayden | ▲ Buy | Option Exercise | 710 | $1K | 11/12/2025 |
| Jeremy B. Hayden | ▲ Buy | Option Exercise | 2,440 | $5K | 11/12/2025 |
| Jeremy B. Hayden | ▼ Sell | Open Market | 3,150 | $25K | 11/12/2025 |
| James Rodberg | ▲ Buy | Grant | 15,337 | $0 | 11/11/2025 |
| Alison Bauerlein | ▲ Buy | Grant | 23,006 | $0 | 11/11/2025 |
| Brenton Taylor | ▼ Sell | Open Market | 591 | $2K | 10/6/2025 |
| David Badawi | ▼ Sell | Open Market | 6,033 | $20K | 10/3/2025 |
| Jeremy B. Hayden | ▼ Sell | Open Market | 9,731 | $32K | 10/3/2025 |
| Alison Bauerlein | ▼ Sell | Open Market | 19,948 | $66K | 10/2/2025 |
| Paul Badawi | ▼ Sell | Open Market | 24,441 | $82K | 10/1/2025 |
| Catherine Mazzacco | ▼ Sell | Gift | 37,492 | $0 | 9/11/2025 |
| Brenton Taylor | ▲ Buy | Grant | 25,840 | $0 | 9/2/2025 |
| David Badawi | ▲ Buy | Option Exercise | 40,000 | $5K | 7/17/2025 |
| Jeremy B. Hayden | ▼ Sell | Open Market | 9,160 | $38K | 7/3/2025 |
| David Badawi | ▼ Sell | Open Market | 5,679 | $24K | 7/3/2025 |
| Link Matthew | ▼ Sell | Open Market | 4,889 | $20K | 7/2/2025 |
| Alison Bauerlein | ▼ Sell | Open Market | 19,260 | $79K | 7/2/2025 |
| Paul Badawi | ▼ Sell | Open Market | 23,637 | $98K | 7/1/2025 |
| Staffan Encrantz | ▲ Buy | Open Market | 27,900 | $118K | 6/6/2025 |
| Staffan Encrantz | ▲ Buy | Open Market | 40,951 | $174K | 6/5/2025 |
| Staffan Encrantz | ▲ Buy | Grant | 30,952 | $0 | 6/5/2025 |
| Donald Zurbay | ▲ Buy | Grant | 30,952 | $0 | 6/5/2025 |
| Erica J. Rogers | ▲ Buy | Grant | 30,952 | $0 | 6/5/2025 |
| Larsen-Becker Brenda Jane | ▲ Buy | Grant | 30,952 | $0 | 6/5/2025 |
| Tamara Fountain | ▲ Buy | Grant | 30,952 | $0 | 6/5/2025 |
| Catherine Mazzacco | ▲ Buy | Grant | 30,952 | $0 | 6/5/2025 |
| Staffan Encrantz | ▲ Buy | Open Market | 21,674 | $90K | 6/4/2025 |
| Staffan Encrantz | ▲ Buy | Open Market | 25,230 | $100K | 6/3/2025 |
| Staffan Encrantz | ▲ Buy | Open Market | 30,799 | $119K | 6/2/2025 |
| Staffan Encrantz | ▲ Buy | Open Market | 42,753 | $157K | 5/30/2025 |
| Staffan Encrantz | ▲ Buy | Open Market | 60,128 | $216K | 5/29/2025 |
| Staffan Encrantz | ▲ Buy | Open Market | 26,715 | $94K | 5/28/2025 |
| Staffan Encrantz | ▲ Buy | Open Market | 41,346 | $142K | 5/27/2025 |
| Alison Bauerlein | ▼ Sell | Open Market | 13,066 | $45K | 5/19/2025 |
| Link Matthew | ▲ Buy | Grant | 6,631 | $20K | 5/16/2025 |
| Raheja Manohar K. | ▲ Buy | Grant | 12,767 | $39K | 5/16/2025 |
| Gerhard F. Burbach | ▲ Buy | Grant | 74,766 | $0 | 5/12/2025 |
| Jeremy B. Hayden | ▼ Sell | Open Market | 9,395 | $22K | 4/2/2025 |
| Link Matthew | ▼ Sell | Open Market | 5,042 | $12K | 4/2/2025 |
| Alison Bauerlein | ▼ Sell | Open Market | 19,397 | $45K | 4/2/2025 |
| Paul Badawi | ▼ Sell | Open Market | 24,174 | $56K | 4/1/2025 |
| David Badawi | ▼ Sell | Open Market | 5,980 | $14K | 4/1/2025 |
| Raheja Manohar K. | ▲ Buy | Open Market | 10,000 | $26K | 3/13/2025 |
| Raheja Manohar K. | ▲ Buy | Open Market | 10,000 | $27K | 3/12/2025 |
| Staffan Encrantz | ▼ Sell | Other | 243,000 | $673K | 3/12/2025 |
| Staffan Encrantz | ▼ Sell | Other | 150,000 | $407K | 3/11/2025 |
| Link Matthew | ▲ Buy | Grant | 172,043 | $0 | 3/11/2025 |
| Paul Badawi | ▲ Buy | Grant | 358,423 | $0 | 3/11/2025 |
| Raheja Manohar K. | ▲ Buy | Grant | 24,000 | $0 | 3/11/2025 |
| Jeremy B. Hayden | ▲ Buy | Grant | 139,785 | $0 | 3/11/2025 |
| David Badawi | ▲ Buy | Grant | 98,566 | $0 | 3/11/2025 |
| Alison Bauerlein | ▲ Buy | Grant | 286,738 | $0 | 3/11/2025 |
| Staffan Encrantz | ▼ Sell | Other | 120,000 | $304K | 3/10/2025 |
| David Badawi | ▼ Sell | Open Market | 5,423 | $15K | 1/17/2025 |
| Jeremy B. Hayden | ▼ Sell | Open Market | 6,922 | $19K | 1/17/2025 |
| Paul Badawi | ▼ Sell | Open Market | 24,819 | $73K | 1/16/2025 |
| Jeremy B. Hayden | ▼ Sell | Open Market | 1,810 | $6K | 1/8/2025 |
| David Badawi | ▼ Sell | Open Market | 3,829 | $12K | 1/8/2025 |
| Paul Badawi | ▼ Sell | Tax Withholding | 12,047 | $43K | 1/7/2025 |
| David Badawi | ▼ Sell | Open Market | 3,111 | $11K | 1/3/2025 |
| Jeremy B. Hayden | ▼ Sell | Open Market | 4,864 | $17K | 1/3/2025 |
| Alison Bauerlein | ▼ Sell | Open Market | 10,102 | $36K | 1/3/2025 |
| Paul Badawi | ▼ Sell | Open Market | 12,236 | $44K | 1/2/2025 |
| Raheja Manohar K. | ▲ Buy | Open Market | 5,000 | $19K | 12/6/2024 |
| Raheja Manohar K. | ▲ Buy | Open Market | 3,376 | $13K | 12/3/2024 |
| Raheja Manohar K. | ▲ Buy | Open Market | 4,624 | $18K | 11/29/2024 |
| Staffan Encrantz | ▼ Sell | Open Market | 551,802 | $2.1M | 11/21/2024 |
| Staffan Encrantz | ▲ Buy | Open Market | 551,802 | $2.1M | 11/21/2024 |
| Raheja Manohar K. | ▲ Buy | Open Market | 2,000 | $7K | 11/19/2024 |
| Raheja Manohar K. | ▲ Buy | Grant | 96,000 | $441K | 11/12/2024 |
| Brenton Taylor | ▲ Buy | Grant | 160,000 | $734K | 11/12/2024 |
| Link Matthew | ▼ Sell | Open Market | 21,831 | $122K | 10/21/2024 |
| Link Matthew | ▼ Sell | Open Market | 20,487 | $122K | 10/18/2024 |
| Link Matthew | ▼ Sell | Open Market | 20,970 | $122K | 10/17/2024 |
| Link Matthew | ▼ Sell | Open Market | 20,734 | $122K | 10/16/2024 |
| Paul Badawi | ▼ Sell | Open Market | 12,727 | $76K | 10/2/2024 |
| David Badawi | ▼ Sell | Open Market | 3,167 | $19K | 10/2/2024 |
| Alison Bauerlein | ▼ Sell | Open Market | 10,130 | $62K | 10/1/2024 |
| Park Sam Boong | ▼ Sell | Open Market | 3,403 | $21K | 10/1/2024 |
| Jeremy B. Hayden | ▼ Sell | Open Market | 4,878 | $30K | 10/1/2024 |
| Jeremy B. Hayden | ▼ Sell | Open Market | 5,055 | $31K | 7/2/2024 |
| Alison Bauerlein | ▼ Sell | Open Market | 10,497 | $65K | 7/2/2024 |
| Park Sam Boong | ▼ Sell | Open Market | 3,525 | $22K | 7/2/2024 |
| David Badawi | ▼ Sell | Open Market | 3,128 | $20K | 7/1/2024 |
| Paul Badawi | ▼ Sell | Open Market | 12,569 | $81K | 7/1/2024 |
| Erica J. Rogers | ▲ Buy | Grant | 17,366 | $0 | 6/6/2024 |
| Staffan Encrantz | ▲ Buy | Grant | 17,366 | $0 | 6/6/2024 |
| Tamara Fountain | ▲ Buy | Grant | 17,366 | $0 | 6/6/2024 |
| Catherine Mazzacco | ▲ Buy | Grant | 17,366 | $0 | 6/6/2024 |
| Larsen-Becker Brenda Jane | ▲ Buy | Grant | 17,366 | $0 | 6/6/2024 |
| Donald Zurbay | ▲ Buy | Grant | 17,366 | $0 | 6/6/2024 |
| Alison Bauerlein | ▼ Sell | Open Market | 13,066 | $71K | 5/17/2024 |
| Paul Badawi | ▼ Sell | Open Market | 12,571 | $64K | 4/3/2024 |
| Alison Bauerlein | ▼ Sell | Open Market | 10,123 | $51K | 4/3/2024 |
| David Badawi | ▼ Sell | Open Market | 3,128 | $16K | 4/3/2024 |
| Park Sam Boong | ▼ Sell | Open Market | 3,414 | $17K | 4/3/2024 |
| Jeremy B. Hayden | ▼ Sell | Open Market | 4,893 | $25K | 4/3/2024 |
| Alison Bauerlein | ▲ Buy | Grant | 315,421 | $0 | 2/14/2024 |
| Jeremy B. Hayden | ▲ Buy | Grant | 151,869 | $0 | 2/14/2024 |
| Paul Badawi | ▲ Buy | Grant | 390,187 | $0 | 2/14/2024 |
| David Badawi | ▲ Buy | Grant | 108,645 | $0 | 2/14/2024 |
| Park Sam Boong | ▲ Buy | Grant | 151,869 | $0 | 2/14/2024 |
| Paul Badawi | ▼ Sell | Open Market | 15,917 | $82K | 1/17/2024 |
| Jeremy B. Hayden | ▼ Sell | Open Market | 4,538 | $23K | 1/17/2024 |
| Park Sam Boong | ▼ Sell | Open Market | 5,443 | $28K | 1/17/2024 |
| David Badawi | ▼ Sell | Open Market | 3,414 | $18K | 1/17/2024 |
| David Badawi | ▼ Sell | Tax Withholding | 2,425 | $13K | 1/3/2024 |
| Paul Badawi | ▼ Sell | Tax Withholding | 8,975 | $46K | 1/3/2024 |
| Jeremy B. Hayden | ▼ Sell | Tax Withholding | 1,227 | $6K | 1/3/2024 |
| Park Sam Boong | ▼ Sell | Tax Withholding | 2,464 | $13K | 1/3/2024 |
| D1 Capital Partners L.P. | ▼ Sell | Open Market | 2,852,036 | $16.7M | 12/27/2023 |
| Staffan Encrantz | ▲ Buy | Open Market | 140,777 | $487K | 11/30/2023 |
| Staffan Encrantz | ▲ Buy | Open Market | 3,223 | $11K | 11/29/2023 |
| Staffan Encrantz | ▲ Buy | Open Market | 253,669 | $877K | 11/28/2023 |
| Staffan Encrantz | ▲ Buy | Open Market | 246,331 | $816K | 11/27/2023 |
| David Badawi | ▲ Buy | Option Exercise | 150,000 | $17K | 11/24/2023 |
| Staffan Encrantz | ▲ Buy | Open Market | 21,855 | $67K | 11/24/2023 |
| Staffan Encrantz | ▲ Buy | Open Market | 41,085 | $103K | 11/22/2023 |
| Staffan Encrantz | ▲ Buy | Open Market | 68,477 | $170K | 11/21/2023 |
| Staffan Encrantz | ▲ Buy | Open Market | 79,234 | $178K | 11/20/2023 |
| Staffan Encrantz | ▲ Buy | Open Market | 126,664 | $277K | 11/17/2023 |
| Staffan Encrantz | ▲ Buy | Open Market | 339 | $678 | 11/16/2023 |
| Staffan Encrantz | ▲ Buy | Open Market | 3,462 | $7K | 11/14/2023 |
| Link Matthew | ▲ Buy | Grant | 747,572 | $0 | 11/14/2023 |
| Park Sam Boong | ▲ Buy | Option Exercise | 31,668 | $62K | 9/14/2023 |
| Park Sam Boong | ▲ Buy | Option Exercise | 6,000 | $12K | 9/14/2023 |
| Erica J. Rogers | ▲ Buy | Grant | 15,094 | $0 | 6/8/2023 |
| Donald Zurbay | ▲ Buy | Grant | 11,940 | $0 | 6/8/2023 |
| Donald Zurbay | ▲ Buy | Grant | 15,094 | $0 | 6/8/2023 |
| Tamara Fountain | ▲ Buy | Grant | 15,094 | $0 | 6/8/2023 |
| Staffan Encrantz | ▲ Buy | Grant | 11,940 | $0 | 6/8/2023 |
| Staffan Encrantz | ▲ Buy | Grant | 15,094 | $0 | 6/8/2023 |
| Erica J. Rogers | ▲ Buy | Grant | 11,940 | $0 | 6/8/2023 |
| Schroeder Valeska | ▲ Buy | Grant | 11,940 | $0 | 6/8/2023 |
| Larsen-Becker Brenda Jane | ▲ Buy | Grant | 15,094 | $0 | 6/8/2023 |
| Catherine Mazzacco | ▲ Buy | Grant | 30,189 | $0 | 6/8/2023 |
| Alison Bauerlein | ▲ Buy | Grant | 103,000 | $0 | 5/9/2023 |
| Paul Badawi | ▲ Buy | Grant | 176,600 | $0 | 3/16/2023 |
| Park Sam Boong | ▲ Buy | Grant | 54,100 | $0 | 3/16/2023 |
| Jeremy B. Hayden | ▲ Buy | Grant | 45,100 | $0 | 3/16/2023 |
| David Badawi | ▲ Buy | Grant | 39,100 | $0 | 3/16/2023 |
| James Rodberg | ▲ Buy | Grant | 20,600 | $0 | 3/16/2023 |
| Larsen-Becker Brenda Jane | ▲ Buy | Grant | 17,923 | $0 | 3/15/2023 |
| Larsen-Becker Brenda Jane | ▼ Sell | Tax Withholding | 2,295 | $21K | 3/15/2023 |
| Tamara Fountain | ▲ Buy | Grant | 17,977 | $0 | 1/8/2023 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 1, 2026
Sight Sciences to Show OMNI Ultra System at 2026 AOO Meeting
Sight Sciences plans to debut its new OMNI Ultra Surgical System at the upcoming American Academy of Ophthalmology Annual Meeting. This event highlights the company's continued focus on advancing ab interno canaloplasty technology. The stock is currently trading near its 52-week high, reflecting strong recent momentum.
Sight Sciences to Show OMNI Ultra System at 2026 AOO Meeting. Sight Sciences plans to debut its new OMNI Ultra Surgical System at the upcoming American Academy of Ophthalmology Annual Meeting. This event highlights the company's continued focus on advancing ab interno canaloplasty technology. The stock is currently trading near its 52-week high, reflecting strong recent momentum.